CA3073142C - Composes de morpholinylpyridone - Google Patents

Composes de morpholinylpyridone

Info

Publication number
CA3073142C
CA3073142C CA3073142A CA3073142A CA3073142C CA 3073142 C CA3073142 C CA 3073142C CA 3073142 A CA3073142 A CA 3073142A CA 3073142 A CA3073142 A CA 3073142A CA 3073142 C CA3073142 C CA 3073142C
Authority
CA
Canada
Prior art keywords
trifluoromethyl
pharmaceutically acceptable
acceptable salt
compound according
methylmorpholin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3073142A
Other languages
English (en)
Other versions
CA3073142A1 (fr
Inventor
Johan Lindstrom
Rickard FORSBLOM
Jenny Viklund
Original Assignee
Sprint Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sprint Bioscience AB filed Critical Sprint Bioscience AB
Priority claimed from PCT/EP2018/072791 external-priority patent/WO2019038390A1/fr
Publication of CA3073142A1 publication Critical patent/CA3073142A1/fr
Application granted granted Critical
Publication of CA3073142C publication Critical patent/CA3073142C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne de nouveaux composés de morpholinylpyridone de formule (I), des compositions pharmaceutiques contenant ces composés, et des procédés d'utilisation de tels composés pour le traitement de maladies, notamment du cancer, du diabète de type II, de maladies inflammatoires, de maladies auto-immunes, de troubles neurodégénératifs, de troubles cardiovasculaires et d'infections virales ; dans la formule, R1, R2 et A sont tels que définis dans la description.
CA3073142A 2017-08-23 2018-08-23 Composes de morpholinylpyridone Active CA3073142C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187567.7 2017-08-23
EP17187567 2017-08-23
PCT/EP2018/072791 WO2019038390A1 (fr) 2017-08-23 2018-08-23 Composés de morpholinylpyridone

Publications (2)

Publication Number Publication Date
CA3073142A1 CA3073142A1 (fr) 2019-02-28
CA3073142C true CA3073142C (fr) 2025-09-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2017219846B2 (en) 6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and diabetes
AU2023285995A1 (en) Morpholinylpyridone Compounds
AU2023258375A1 (en) Pyridylpyridone Compounds
IL272792A (en) Azaindolylpyridone and diazaindolylpyridone compounds
CA3073142C (fr) Composes de morpholinylpyridone
HK40079060A (en) Morpholinylpyridone compounds
RU2803158C2 (ru) Морфолинилпиридоны
CA3072861C (fr) Composes d'azaindolylpyridone et de diazaindolylpyridone
CA3072974C (fr) Composes de pyridylpyridone
HK40030345B (en) Morpholinylpyridone compounds
CA3015005C (fr) Composes 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one utilises pour le traitement du cancer et du diabete
CA3015045C (fr) Composes 6-aryl-4-morpholin-1-yl-pyridone utilises pour le traitement du cancer et du diabete